| Status | Study |
| Recruiting |
Study Name: Telomere Biology in Early Adenocarcinoma of the Lung Condition: Adenocarcinoma of the Lung Adenocarcinoma, Bronchiolo-Alveolar Date: 2014-09-10 |
| Active, not recruiting |
Study Name: Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer Condition: Adenocarcinoma of the Lung Adenosquamous Cell Lung Cancer Date: 2013-10-07 Interventions: Dietary Supplement: soy isoflavones |
| Completed |
Study Name: Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Condition: Adenocarcinoma of the Lung Adenosquamous Cell Lung Cancer Date: 2012-02-14 Interventions: Drug: cisplatin Given IV |
| Terminated |
Study Name: Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer Condition: Large Cell Lung Carcinoma Lung Adenocarcinoma Recurrent No Date: 2009-08-07 Interventions: Biological: Bevacizumab Given |
| Active, not recruiting |
Study Name: S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma Condition: Lung Cancer Date: 2007-02-15 Interventions: Biological: bevacizumab Drug: erlotinib hy |
| Completed |
Study Name: Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma Condition: Lung Cancer Adenocarcinoma Date: 2007-01-30 Interventions: Drug: sunitinib 50mg po qd x 4 weeks on followed by 2 weeks off for a 6 week cycle. |
| Completed |
Study Name: Therapeutic Strategy in Advanced Bronchioloalveolar Carcinoma Condition: Adenocarcinoma, Bronchiolo-Alveolar Date: 2006-10-05 Interventions: Drug: erlotinib Erlotinib 150 |
| Terminated |
Study Name: Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer Condition: Adenocarcinoma of the Lung Bronchoalveolar Cell Lung Cancer Date: 2006-08-24 Interventions: Radiation: 3-dimensional conformal radiation therapy |
| Completed |
Study Name: S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer Condition: Adenocarcinoma of the Lung Adenosquamous Cell Lung Cancer Date: 2006-08-24 Interventions: Biological: cetuximab Given IV |
| Completed |
Study Name: First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene Condition: Lung Neoplasms Non-Small Cell Lung Cancer Date: 2006-06-19 Interventions: Drug: Erlotinib |